Last update 08 May 2025

CLDN6 x CLDN9 x DNA

Basic Info

Related Targets
CLDN6CLDN9DNA

Related

1
Drugs associated with CLDN6 x CLDN9 x DNA
SC-004(Stemcentrx)
Target
CLDN6 x CLDN9 x DNA
Mechanism
CLDN6 inhibitors [+2]
Active Org.-
Originator Org.
Stemcentrx, Inc.Stemcentrx, Inc.
Active Indication-
Inactive Indication
Endometrial Carcinoma [+3]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CLDN6 x CLDN9 x DNA
NCT03138408
/ TerminatedPhase 1
An Open Label, Phase 1 Study of SC-004 as Monotherapy and in Combination With ABBV-181 in Subjects With Epithelial Ovarian, Including Fallopian Tube and Primary Peritoneal and Endometrial Cancers
100 Clinical Results associated with CLDN6 x CLDN9 x DNA
Login to view more data
100 Translational Medicine associated with CLDN6 x CLDN9 x DNA
Login to view more data
0 Patents (Medical) associated with CLDN6 x CLDN9 x DNA
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free